1 – 7 of 7
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Scaling behaviour and rate-determining steps in filamentous self-assembly
(
- Contribution to journal › Article
-
Mark
Systematic development of small molecules to inhibit specific microscopic steps of Aβ42 aggregation in Alzheimer's disease
2017) In Proceedings of the National Academy of Sciences of the United States of America 114(2). p.200-208(
- Contribution to journal › Article
- 2016
-
Mark
An anticancer drug suppresses the primary nucleation reaction that initiates the production of the toxic Aβ42 aggregates linked with Alzheimer's disease.
(
- Contribution to journal › Article
-
Mark
Microfluidic Diffusion Analysis of the Sizes and Interactions of Proteins under Native Solution Conditions.
(
- Contribution to journal › Article
- 2015
-
Mark
A molecular chaperone breaks the catalytic cycle that generates toxic Aβ oligomers.
(
- Contribution to journal › Article
- 2014
-
Mark
Differences in nucleation behavior underlie the contrasting aggregation kinetics of the Aβ40 and Aβ42 peptides.
(
- Contribution to journal › Article
- 2013
-
Mark
Proliferation of amyloid-beta 42 aggregates occurs through a secondary nucleation mechanism
(
- Contribution to journal › Article